Kenneth L. Londoner - 20 May 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth L. Londoner
Issuer symbol
BSGM
Transactions as of
20 May 2022
Net transactions value
+$17,663
Form type
4
Filing time
24 May 2022, 13:51:56 UTC
Previous filing
08 Apr 2022
Next filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSGM Common Stock Purchase $4,124 +3,650 +0.22% $1.13 1,682,894 20 May 2022 Direct
transaction BSGM Common Stock Purchase $13,539 +11,850 +0.7% $1.14 1,694,744 23 May 2022 Direct F1
holding BSGM Common Stock 1,181,324 20 May 2022 By Endicott Management Partners, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 The reporting person is the beneficial owner of Endicott Management Partners, LLC.